Clinical Trial Update: A Phase I/II Study to Evaluate the Safety, Pharmacokinetics and Efficacy of PRJ1-3024 in Subjects with Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the safety, pharmacokinetics and preliminary efficacy of PRJ1-3024 in patients with advanced solid tumors; recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumors

Drugs mentioned

• PRJ1-3024

Snippet

Sponsor: Zhuhai Yufan Biotechnologies Co., Ltd | Conditions: Advanced Solid Tumor, Advanced Solid Malignancies | Phase 1, Phase 2 | Status: RECRUITING